
Biomarkers and Precision Oncology Forum/LinkedIn
Jul 28, 2025, 01:27
Optimising Patient Outcomes with PARP inhibitors Maintenance for Advanced Ovarian Cancer – Biomarkers and Precision Oncology Forum
Biomarkers and Precision Oncology Forum shared a post on LinkedIn:
“Featured talk supported by GSK — Not to be missed: Dr. Valerie Heong of Tan Tock Seng Hospital, Singapore, presents “Optimising Patient Outcomes with PARP inhibitors Maintenance for Advanced Ovarian Cancer” at BPOF 2025.
Explore evolving strategies in ovarian cancer care from a clinical and therapeutic lens in one of the forum’s key spotlight sessions.
31 July 2025 | 11:05–11:20 SGT
Grand Hyatt, Singapore
More posts about Ovarian Cancer on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 28, 2025, 03:49
Jul 27, 2025, 20:55
Jul 27, 2025, 19:47